(Total Views: 587)
Posted On: 12/21/2021 12:06:47 PM
Post# of 151607
Does today's communication from the FDA constitute a more accepting posture towards Leronlimab and Cytodyn by the FDA?
Could this revised position of the FDA have anything to do with Janet Woodcock's departure?
Could this revised position of the FDA have anything to do with Janet Woodcock's departure?
(3)
(0)
The Lawman
style="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]
Scroll down for more posts ▼
